Alumis Inc. Common Stock
Status: Publicly traded
Direct answer
Alumis Inc. Common Stock is publicly traded on NASDAQ under the ticker ALMS.
Alumis Inc. is a biopharmaceutical firm currently in the clinical trial phase, dedicated to advancing and marketing therapeutic solutions for a range of autoimmune conditions. Its pipeline includes ESK-001, an allosteric tyrosine kinase 2 (TYK2) inhibitor, which is being investigated for its potential in addressing plaque psoriasis, systemic lupus erythematosus, and non-infectious uveitis. Another key candidate is...
Can you invest in Alumis Inc. Common Stock?
Yes. Alumis Inc. Common Stock trades publicly on NASDAQ as ALMS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Alumis Inc. Common Stock
Detailed equity research is provided by MarketSnap.